奕瑞科技:2024Q3收入承压,定增申请获上交所受理

奕瑞科技(688301.SH) 医疗器械 证券研究报告/公司点评报告 2024 年 10 月 27 日 2024Q3 收入承压,定增申请获上交所受理 | --- | --- | --- | --- | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...